NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

You got it wrong. 14% down is meaningless to the NWBO longs. Nine months ago, we didn't know RevImmune solely owned by LP. We didn't know LP tackled a very challenging issue of automatically isolating dendritic cells while keeping them intact. We didn't know there was article that would be published in Nature. We didn't know the application package was filed. We didn't know a lot of things nine months ago.

Knowing all these things, we don't think sp goes down. Instead sp goes up a lot because of the expansion of the potential value.
And I was able to continue averaging down.

Do pass my thanks to your boss for me.